Compare CDNA & UEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | UEC |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.6B |
| IPO Year | 2007 | 2008 |
| Metric | CDNA | UEC |
|---|---|---|
| Price | $84.86 | $7.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $65.33 | $16.03 |
| AVG Volume (30 Days) | 1.3M | ★ 9.1M |
| Earning Date | 10-29-2026 | 12-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.45 | N/A |
| Revenue | ★ $48,324,000.00 | $37,250,000.00 |
| Revenue This Year | $30.36 | $70.84 |
| Revenue Next Year | $6.23 | $178.50 |
| P/E Ratio | $33.32 | ★ N/A |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $14.27 | $6.75 |
| 52 Week High | $73.43 | $20.34 |
| Indicator | CDNA | UEC |
|---|---|---|
| Relative Strength Index (RSI) | 79.73 | 37.60 |
| Support Level | $17.30 | $7.27 |
| Resistance Level | N/A | $10.31 |
| Average True Range (ATR) | 4.65 | 0.45 |
| MACD | 0.83 | 0.07 |
| Stochastic Oscillator | 80.27 | 42.96 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Uranium Energy Corp is engaged in uranium mining and related activities, including exploration, permitting, pre-extraction, extraction, recovery, and processing. The Company undertakes conventional and ISR uranium extraction and recovery and the exploration, permitting, and evaluation of uranium properties in the United States, Canada, and the Republic of Paraguay. Its principal projects are located in Wyoming and Texas in the United States and Saskatchewan, Canada. The Company operates three hub-and-spoke platforms in South Texas and Wyoming, anchored by licensed CPPs and served by ISR and conventional uranium projects. Its operating segments consist of uranium exploration and mining activities in Wyoming, Texas, Saskatchewan, and others, with Wyoming generating maximum revenue.